Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Boehringer Ingelheim
Argus Health
Novartis
Fish and Richardson
Teva
Chinese Patent Office
Express Scripts
QuintilesIMS
Fuji

Generated: January 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019660

« Back to Dashboard

NDA 019660 describes TILADE, which is a drug marketed by King Pharms Llc and Sanofi Aventis Us and is included in two NDAs. Additional details are available on the TILADE profile page.

The generic ingredient in TILADE is nedocromil sodium. There are three drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the nedocromil sodium profile page.
Summary for 019660
Tradename:TILADE
Applicant:King Pharms Llc
Ingredient:nedocromil sodium
Patents:0
Therapeutic Class:Ophthalmic Agents
Respiratory Tract Agents
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 019660

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:AEROSOL, METERED;INHALATIONStrength1.75MG/INH
Approval Date:Dec 30, 1992TE:RLD:No

Expired US Patents for NDA 019660

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
King Pharms Llc TILADE nedocromil sodium AEROSOL, METERED;INHALATION 019660-001 Dec 30, 1992 ➤ Subscribe ➤ Subscribe
King Pharms Llc TILADE nedocromil sodium AEROSOL, METERED;INHALATION 019660-001 Dec 30, 1992 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Fuji
Deloitte
Mallinckrodt
Accenture
Medtronic
Boehringer Ingelheim
Harvard Business School
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot